Searching journal content for carcinoma (as phrase) in full text.

Displaying results 1-10 of 1534
For checked items
  1. Review:
    • Vincenzo Marotta,
    • Maria Chiara Zatelli,
    • Concetta Sciammarella,
    • Maria Rosaria Ambrosio,
    • Marta Bondanelli,
    • Annamaria A L Colao,
    • and Antongiulio Faggiano
    Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer ERC-17-0269, doi:10.1530/ERC-17-0269 first published on 24 October 2017
    ..., including those arising from 80 the gastroenteropancreatic tract and the bronchopulmonary area, which represent the majority, but 81 also pheocromocytomas/paragangliomas, medullary thyroid carcinoma, Merkel cell carcinoma of 82 the skin, and (even if data are controversial) pituitary and parathyroid ~~~
  2. Research:
    • B Wan,
    • L Dai,
    • L Wang,
    • Y Zhang,
    • H Huang,
    • G Qian,
    • and T Yu
    Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells Endocr Relat Cancer ERC-17-0261, doi:10.1530/ERC-17-0261 first published on 24 October 2017
    ...to 428 cisplatin. Critical Reviews in Toxicology 40 347-359. 429 Claerhout S, Verschooten L, Van Kelst S, De Vos R, Proby C, Agostinis P & Garmyn M 2010 430 Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced 431 apoptosis of metastatic skin carcinoma. International ~~~
  3. Research:
    • Willem Corver,
    • Joris Demmers,
    • Jan Oosting,
    • Shima Sahraeian,
    • Arnoud Boot,
    • Dina Ruano,
    • Ton Van Wezel,
    • and Hans Morreau
    ROS-induced near-homozygous genomes in thyroid cancer Endocr Relat Cancer ERC-17-0288, doi:10.1530/ERC-17-0288 first published on 24 October 2017
    ...in vitro findings in clinical samples and searched for the sequence of whole-97 Page 5 of 59 chromosome gains or losses in the progression of oncocytic thyroid follicular adenoma to 98 carcinoma. 99 100 Page 6 of 59 METHODS 101 102 Patient material 103 Selection of cases: SNP-array and flow cytometric DNA ~~~
  4. Review:
    • Joanna Grey and
    • Kym Winter
    Patient quality of life and prognosis in MEN2 Endocr Relat Cancer ERC-17-0335, doi:10.1530/ERC-17-0335 first published on 24 October 2017
    ...) refers to the autosomal dominant neuroendocrine 7 tumour syndromes, MEN type 2A (MEN2A) and MEN type 2B (MEN2B). They are typified by the 8 development of medullary thyroid carcinoma (MTC), phaeochromocytoma and parathyroid 9 hyperplasia in MEN2A, and MTC, phaeochromocytomas, ganglioneuromatosis ~~~
  5. Research:
    • Amruta Ashtekar,
    • Danielle Huk,
    • Alexa Magner,
    • Krista La Perle,
    • Xiaoli Zhang,
    • José I Piruat,
    • José López-Barneo,
    • Sissy M Jhiang,
    • and Lawrence S Kirschner
    Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype Endocr Relat Cancer 24 (11) 579-591, doi:10.1530/ERC-17-0229 first published on 19 September 2017
    ...subunits of SDH can lead to PHEO, PGL, renal cell carcinoma, gastrointestinal stromal tumor, thyroid cancer and breast cancer (Bardella et al. 2011, Xiaoetal.2012, Letouze etal. 2013, Millan-Ucles etal. 2014, Williamson etal. 2015). Dysfunction of these metabolic enzymes has provided new insight ~~~
  6. Research:
    • Zhu Wang,
    • Dinglan Wu,
    • Chi-Fai Ng,
    • Jeremy Yuen-Chun Teoh,
    • Shan Yu,
    • Yuliang Wang,
    • and Franky Leung Chan
    Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer Endocr Relat Cancer ERC-17-0280, doi:10.1530/ERC-17-0280 first published on 17 October 2017
    ...and androgen injection on serum phosphatases in metastatic carcinoma of the 478 prostate. CA Cancer J Clin 22 232-240. 479 Jeong Y & Mangelsdorf DJ 2009 Nuclear receptor regulation of stemness and stem cell 480 differentiation. Exp Mol Med 41 525-537. 481 Jeong Y, Xie Y, Lee W, Bookout AL, Girard L, Raso G ~~~
  7. Research:
    • Luis Furuya-Kanamori,
    • Art Sedrakyan,
    • Adedayo A Onitilo,
    • Nasser Bagheri,
    • Paul Glasziou,
    • and Suhail A. R. Doi
    Differentiated thyroid cancer: millions spent with no tangible gain? Endocr Relat Cancer ERC-17-0397, doi:10.1530/ERC-17-0397 first published on 17 October 2017
    ...increasing (Sung et al., 2014, 65 Ahn and Welch, 2015). For example, DTC overdetection in small papillary carcinomas is 66 leading to unnecessary thyroidectomies with no real survival advantage delivered to patients 67 (Davies and Welch, 2006, Enewold et al., 2011). After surgery most patients would require ~~~
  8. Review:
    • Priscilla Cukier,
    • Fernando C Santini,
    • Mariana Scaranti,
    • and Ana O Hoff
    Endocrine side effects of cancer immunotherapy Endocr Relat Cancer ERC-17-0358, doi:10.1530/ERC-17-0358 first published on 12 October 2017
    ...of different cancers by the United States Food and Drug 33 Administration (FDA) including: melanoma, non-small cell lung cancer (NSCLC), head 34 and neck cancer, renal cell carcinoma, urothelial cancer, merkel cell carcinoma, 35 Hodgkins lymphoma, and mismatch-repair deficient cancers (Table 1). Of note, 36 ~~~
  9. Research:
    • Justin Brown,
    • Michael Rickels,
    • Andrea Troxel,
    • Babette Zemel,
    • Nevena Damjanov,
    • Bonnie Ky,
    • Andrew Rhim,
    • Anil Rustgi,
    • Kerry S Courneya,
    • and Kathryn Schmitz
    Dose-response effects of exercise on insulin among colon cancer survivors Endocr Relat Cancer ERC-17-0377, doi:10.1530/ERC-17-0377 first published on 10 October 2017
    ...insulin-like growth factor regulates the liver stromal response to 354 metastatic colon carcinoma cells. Oncotarget. 355 Page 15 of 25 Fitzmaurice GM, Laird NM & Ware JH 2012 Applied longitudinal analysis: John Wiley & Sons. 356 Friedenreich CM, Neilson HK, Woolcott CG, McTiernan A, Wang Q, Ballard ~~~
  10. Research:
    • Keren Cohen,
    • Uri Abadi,
    • Aleck Hercbergs,
    • Paul J Davis,
    • Martin Ellis,
    • and Osnat Ashur-Fabian
    The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative Endocr Relat Cancer ERC-17-0246, doi:10.1530/ERC-17-0246 first published on 10 October 2017
    ..., Yamamura Y, Kau S, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, 508 Theriault R & Hortobagyi G 2005 Thyroid hormone and breast carcinoma. Primary 509 hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 510 103 1122-1128. 511 Dalamaga M, Karmaniolas K ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most